Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4HNJ8
Term | Name | Level | Count |
---|---|---|---|
GO:0006793 | phosphorus metabolic process | 3 | 9 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 9 |
GO:0007165 | signal transduction | 2 | 9 |
GO:0007186 | G protein-coupled receptor signaling pathway | 3 | 9 |
GO:0007205 | protein kinase C-activating G protein-coupled receptor signaling pathway | 4 | 9 |
GO:0008152 | metabolic process | 1 | 9 |
GO:0009987 | cellular process | 1 | 9 |
GO:0016310 | phosphorylation | 5 | 9 |
GO:0044237 | cellular metabolic process | 2 | 9 |
GO:0050789 | regulation of biological process | 2 | 9 |
GO:0050794 | regulation of cellular process | 3 | 9 |
GO:0065007 | biological regulation | 1 | 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 9 |
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004143 | diacylglycerol kinase activity | 5 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0005524 | ATP binding | 5 | 9 |
GO:0016301 | kinase activity | 4 | 9 |
GO:0016740 | transferase activity | 2 | 9 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 9 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 9 |
GO:0017076 | purine nucleotide binding | 4 | 9 |
GO:0030554 | adenyl nucleotide binding | 5 | 9 |
GO:0032553 | ribonucleotide binding | 3 | 9 |
GO:0032555 | purine ribonucleotide binding | 4 | 9 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 9 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 9 |
GO:0036094 | small molecule binding | 2 | 9 |
GO:0043167 | ion binding | 2 | 9 |
GO:0043168 | anion binding | 3 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:0097367 | carbohydrate derivative binding | 2 | 9 |
GO:1901265 | nucleoside phosphate binding | 3 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.244 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.292 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.279 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.276 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.306 |
CLV_PCSK_PC1ET2_1 | 92 | 94 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.321 |
CLV_PCSK_SKI1_1 | 32 | 36 | PF00082 | 0.313 |
DEG_MDM2_SWIB_1 | 289 | 297 | PF02201 | 0.490 |
DEG_ODPH_VHL_1 | 368 | 381 | PF01847 | 0.172 |
DOC_CYCLIN_RxL_1 | 218 | 226 | PF00134 | 0.362 |
DOC_CYCLIN_yCln2_LP_2 | 367 | 373 | PF00134 | 0.172 |
DOC_MAPK_gen_1 | 227 | 235 | PF00069 | 0.454 |
DOC_MAPK_gen_1 | 9 | 18 | PF00069 | 0.562 |
DOC_MAPK_MEF2A_6 | 228 | 237 | PF00069 | 0.479 |
DOC_PP1_RVXF_1 | 13 | 19 | PF00149 | 0.446 |
DOC_PP1_RVXF_1 | 297 | 303 | PF00149 | 0.490 |
DOC_PP2B_LxvP_1 | 353 | 356 | PF13499 | 0.531 |
DOC_PP2B_LxvP_1 | 367 | 370 | PF13499 | 0.351 |
DOC_WW_Pin1_4 | 98 | 103 | PF00397 | 0.427 |
LIG_14-3-3_CanoR_1 | 156 | 160 | PF00244 | 0.525 |
LIG_BRCT_BRCA1_1 | 120 | 124 | PF00533 | 0.362 |
LIG_BRCT_BRCA1_1 | 182 | 186 | PF00533 | 0.423 |
LIG_Clathr_ClatBox_1 | 234 | 238 | PF01394 | 0.467 |
LIG_deltaCOP1_diTrp_1 | 45 | 51 | PF00928 | 0.467 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.574 |
LIG_FHA_1 | 205 | 211 | PF00498 | 0.511 |
LIG_FHA_1 | 311 | 317 | PF00498 | 0.467 |
LIG_FHA_1 | 339 | 345 | PF00498 | 0.491 |
LIG_FHA_2 | 112 | 118 | PF00498 | 0.423 |
LIG_FHA_2 | 150 | 156 | PF00498 | 0.534 |
LIG_FHA_2 | 267 | 273 | PF00498 | 0.362 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.552 |
LIG_GBD_Chelix_1 | 375 | 383 | PF00786 | 0.243 |
LIG_LIR_Apic_2 | 272 | 277 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 136 | 146 | PF02991 | 0.628 |
LIG_LIR_Gen_1 | 361 | 372 | PF02991 | 0.319 |
LIG_LIR_Gen_1 | 45 | 56 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 73 | 78 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 136 | 142 | PF02991 | 0.534 |
LIG_LIR_Nem_3 | 361 | 367 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 73 | 77 | PF02991 | 0.516 |
LIG_LYPXL_yS_3 | 201 | 204 | PF13949 | 0.362 |
LIG_PCNA_TLS_4 | 60 | 67 | PF02747 | 0.467 |
LIG_Pex14_1 | 214 | 218 | PF04695 | 0.423 |
LIG_Pex14_2 | 124 | 128 | PF04695 | 0.493 |
LIG_Pex14_2 | 178 | 182 | PF04695 | 0.436 |
LIG_Pex14_2 | 289 | 293 | PF04695 | 0.490 |
LIG_PTB_Apo_2 | 176 | 183 | PF02174 | 0.490 |
LIG_SH2_CRK | 274 | 278 | PF00017 | 0.490 |
LIG_SH2_NCK_1 | 146 | 150 | PF00017 | 0.554 |
LIG_SH2_PTP2 | 74 | 77 | PF00017 | 0.467 |
LIG_SH2_SRC | 74 | 77 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 215 | 219 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 382 | 385 | PF00017 | 0.312 |
LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.467 |
LIG_SH3_3 | 103 | 109 | PF00018 | 0.453 |
LIG_SH3_3 | 239 | 245 | PF00018 | 0.422 |
LIG_Sin3_3 | 364 | 371 | PF02671 | 0.262 |
LIG_SUMO_SIM_par_1 | 231 | 238 | PF11976 | 0.467 |
LIG_WW_3 | 355 | 359 | PF00397 | 0.585 |
MOD_CDC14_SPxK_1 | 101 | 104 | PF00782 | 0.427 |
MOD_CDK_SPxK_1 | 98 | 104 | PF00069 | 0.427 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.467 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.535 |
MOD_Cter_Amidation | 304 | 307 | PF01082 | 0.290 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.401 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.331 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.216 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.283 |
MOD_GSK3_1 | 145 | 152 | PF00069 | 0.581 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.527 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.490 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.429 |
MOD_N-GLC_1 | 266 | 271 | PF02516 | 0.181 |
MOD_N-GLC_1 | 331 | 336 | PF02516 | 0.281 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.444 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.547 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.474 |
MOD_NEK2_1 | 331 | 336 | PF00069 | 0.612 |
MOD_NEK2_1 | 347 | 352 | PF00069 | 0.490 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.559 |
MOD_NEK2_1 | 381 | 386 | PF00069 | 0.273 |
MOD_NEK2_2 | 338 | 343 | PF00069 | 0.514 |
MOD_PIKK_1 | 347 | 353 | PF00454 | 0.440 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.479 |
MOD_Plk_4 | 229 | 235 | PF00069 | 0.483 |
MOD_ProDKin_1 | 98 | 104 | PF00069 | 0.427 |
TRG_DiLeu_BaEn_2 | 359 | 365 | PF01217 | 0.427 |
TRG_DiLeu_BaEn_2 | 61 | 67 | PF01217 | 0.420 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.428 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.444 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.415 |
TRG_ENDOCYTIC_2 | 74 | 77 | PF00928 | 0.467 |
TRG_ER_diArg_1 | 137 | 139 | PF00400 | 0.441 |
TRG_ER_diArg_1 | 197 | 200 | PF00400 | 0.467 |
TRG_ER_diArg_1 | 8 | 11 | PF00400 | 0.614 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKR4 | Leptomonas seymouri | 67% | 100% |
A0A0S4KIS7 | Bodo saltans | 25% | 87% |
A0A1X0NZZ0 | Trypanosomatidae | 36% | 100% |
A0A3Q8IIW3 | Leishmania donovani | 81% | 100% |
A4IC67 | Leishmania infantum | 81% | 100% |
C9ZVX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 67% |
E9AG10 | Leishmania major | 80% | 100% |
E9B763 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
F4JQ95 | Arabidopsis thaliana | 24% | 79% |
P52429 | Homo sapiens | 34% | 68% |
Q1PDI2 | Arabidopsis thaliana | 25% | 79% |
Q8VZG1 | Arabidopsis thaliana | 26% | 79% |
Q9R1C6 | Mus musculus | 35% | 69% |
V5AWH3 | Trypanosoma cruzi | 37% | 100% |